Reconsideration Decisions: Drugs

Health Canada's Summary Basis of Reconsideration Decision (SBRD) documents outline the scientific and regulatory considerations that factored into Health Canada's decision to grant or deny a Request for Reconsideration filed as per the Health Canada Guidance Document: Reconsideration of Final Decisions Issued for Human Drug Submissions. The SBRD documents are prepared to inform stakeholders of decisions made, without disclosing potentially confidential information about a submission that may not have received authorization.

SBRD documents should be read in conjunction with the relevant sections of other applicable guidance documents.

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: